Incidence and mortality of cervical cancer in Latin America

Salud Publica de Mexico

Volumn 45, Issue SUPPL. 3, 2003, Pages

  Arrossi, Silvina ^a   Sankaranarayanan, Rengaswamy ^a   Parkin, Donald Maxwell ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cervical cancer; Incidence; Latin America; Mortality, public health

Indexed keywords

AFRICA; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CENTRAL AMERICA; FEMALE; HAITI; HEALTH PROGRAM; HUMAN; SOUTH AMERICA; SOUTHEAST ASIA; UTERINE CERVIX CANCER;

EID: 0346158939     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-36342003000900004     Document Type: Article

References (38)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:s4-s66.
2. Restrepo H. Cancer epidemiology and control in women in Latin America and the Caribbean. In: Gómez E. ed. Gender, women, and health in the Americas. Washington, DC: PAHO, 1993 Scientific Publication: No. 541. 90-103.
3. Robles SC, White F, Peruga A. Trends in cervical cancer mortality in the Americas. Bull Pan Am Health Organ 2002;30:290-3011.
4. Parkin DM. Screening for cervix cancer in developing countries. In: Miller AB, Chamberlain J, Day NE, Hakama M Prorok PC, ed Cancer screening. Cambridge: UICC, 1991;184-198.
5. Hakama M, Hakulinen T, Pukkala E, Saxen E, Teppo L. Risk indicators of breast and cervical cancer on ecologic and individual levels. Am J Epidemiol 1982;116:990-1000.
6. Hakulinen T, Hansluwka H, López AD, Nakada T. Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol 1986;15: 226-233.
7. Hakulinen T, Teppo L, Saxen E. Do the predictions for cancer incidence come true? Experience from Finland. Cancer 1986;57:2454-2458.
8. Ferlay J, Bray F, Pisani P, Parkin DM, ed GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, 2001; Version 1.0. IARC CancerBase No. 5.
9. PAHO. Health statistics from the Americas. Washington, DC: PAHO, 1998; Scientific Publication No. 567.
10. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J ed. Cancer incidence in five continents Lyon: IARC, 1997; Scientific Publication No. 143, VolVII.
11. World Health Organization, WHO Mortality Databank. Internet address: http://www-dep.iarc.fr/dataava/infodata.htm.
12. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-841.
13. Parkin DM, Chen VW, Ferlay J, Galceran J, Storm H, Whelan S. Comparability and quality control in cancer registration. Lyon: IARC, 1994; Technical Report No. 19.
14. Mitacek EJ, St Vallieres D, Polednak AP. Cancer in Haiti 1979-84: Distribution of various forms of cancer according to geographical area and sex. Int J Cancer 1986;38:9-16.
15. United Nations. World population prospects: The 2000 Revision. Comprehensive Tables. New York (NY): United Nations, 2001; Vol I.
16. Parkin DM. The epidemiological basis for evaluating screening policies. In: Franco E, and Monsonego J ed. New Developments in cervical cancer screening and prevention. Oxford: Blackwell Science. 1997;51-69.
17. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
18. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
19. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Francheschi S, Meijer CJ et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-333.
20. Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-420.
21. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-474.
22. Bosch FX, de Sanjosé S, Castellsague X, Muñoz N. Geographical and social patterns of cervical cancer incidence. In: Franco E, Monsonego J, ed. New developments in cervical cancer screening and prevention. Oxford: Blackwell Science, 1997;23-33.
23. Muñoz N, Francheschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV et al. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 2002;359:1093-1101.
24. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME et al. HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica. Br J Cancer 2001;84:1219-1226
25. Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet 2002;359:1085-1092.
26. Santos C, Muñoz N, Klug S, Almonte M, Guerrero I, Alvarez M et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001;85:966-971.
27. Drain PK, Holmes KK, Hughes JP, Koutsky LA. Determinants of cervical cancer rates in developing countries. Int J Cancer 2002;100:199-205.
28. Hernández-Avila M, Lazcano-Ponce EC, de Ruiz PA, Romieu I. Evaluation of the cervical cancer screening programme in Mexico: A population-based case-control study. Int J Epidemiol 1998;27:370-376.
29. Jiménez-Pérez M, Thomas DB. Has the use of pap smears reduced the risk of invasive cervical cancer in Guadalajara, Mexico? Int J Cancer 1999;82:804-809.
30. Aristizabal N, Cuello C, Correa P, Collazos T, Haenszel W. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer 1984;34:5-9.
31. Herrero R, Brinton LA, Reeves WC, Brenes MM, de Britton RC, Gaitan E et al. Screening for cervical cancer in Latin America: A case-control study. Int J Epidemiol 1992;21:1050-1056.
32. Lazcano-Ponce EC, Alonso de Ruiz P, López-Carrillo L, Nájera-Aguilar P, Avila-Ceniceros R, Escandón-Romero C et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. Acta Cytol 1997 Mar-Apr;41(2):277-284
33. Pan American Health Organization. Evaluation of the cervical cancer control program in Cuba (Short Communication). Bull Pan Am Health Organ 1996;30:387-391.
34. Taucher E, Albala C, Icaza G. Adult Mortality from chronic diseases in Chile, 1986-90. In: Timaeus I, Chackiel J, Ruzicka L, ed. Adult mortality in Latin America. Oxford: Clarendon Press, 1996:253-275.
35. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001;79:954-962.
36. Frenk J, Bobadilla SL, Lozano R. The epidemiological transition in Latin America. In: Timaeus I, Chackiel J, Ruzicka L, ed. Adult mortality in Latin America Oxford: Clarendon Press, 1996:123-139.
37. Argentina, Ministry of Health. Estadísticas vitales. Información básica año 2000. Buenos Aires: Dirección de Estadísticas e Información de Salud, 2000
38. Franco E, Duarte-Franco E, Ferenczy A. Cervical cancer: Epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001;164(7):1017-1025.